Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1985-03-23

AUTHORS

Jan E Carlsen, Troels Kardel, Jens O Lund, Allan McNair, Jens Trap‐Jensen

ABSTRACT

In a double-blind, randomized, crossover study, the effects of intravenous pinacidil, 0.2 mg/kg, were compared with those of hydralazine, 0.3 mg/kg, before and after beta-adrenoceptor blockade in six subjects with hypertension. Both drugs equally reduced total peripheral resistance by about 40%. Pinacidil reduced mean blood pressure by an average of 30 mm Hg, while the reduction after hydralazine was 10 mm Hg. The difference in antihypertensive effect resulted from greater increases in heart rate, cardiac contractility (systolic time intervals), and cardiac index (thermodilution) after hydralazine. These effects after hydralazine could not be fully abolished by beta-blockade, as could the effects after pinacidil. Pinacidil decreased pulmonary blood pressure, whereas there was a slight rise in pulmonary blood pressure after hydralazine. Forearm blood flow (venous occlusion strain gauge plethysmography) increased equally after both drugs; thus pinacidil decreased forearm vascular resistance more than hydralazine did. Serum concentrations of both drugs were within the therapeutic range and correlated with the fall in mean blood pressure. Five subjects complained of side effects after hydralazine, but none were reported after pinacidil. Hydralazine increased myocardial oxygen consumption (as estimated from the rate-pressure product) by 35%; there was no change after pinacidil. It is suggested that hydralazine has direct cardiostimulatory effects that limit its antihypertensive effectiveness. These effects increase myocardial oxygen consumption and may be responsible for the common and sometimes severe cardiovascular side effects of hydralazine. More... »

PAGES

253-259

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/clpt.1985.36

DOI

http://dx.doi.org/10.1038/clpt.1985.36

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1048464171

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/2857601


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1116", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Physiology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adrenergic beta-Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiac Output", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Evaluation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Interactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Guanidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemodynamics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydralazine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metoprolol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pinacidil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Random Allocation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stroke Volume", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Resistance", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Clinical Physiology, Frederiksberg Hospital", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine C, Diakonissestiftelsen", 
            "Department of Clinical Physiology, Frederiksberg Hospital"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carlsen", 
        "givenName": "Jan E", 
        "id": "sg:person.01172441075.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172441075.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Physiology, Frederiksberg Hospital", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine C, Diakonissestiftelsen", 
            "Department of Clinical Physiology, Frederiksberg Hospital"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kardel", 
        "givenName": "Troels", 
        "id": "sg:person.015552033506.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015552033506.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Physiology, Frederiksberg Hospital", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine C, Diakonissestiftelsen", 
            "Department of Clinical Physiology, Frederiksberg Hospital"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lund", 
        "givenName": "Jens O", 
        "id": "sg:person.0613041032.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613041032.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Physiology, Frederiksberg Hospital", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine C, Diakonissestiftelsen", 
            "Department of Clinical Physiology, Frederiksberg Hospital"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McNair", 
        "givenName": "Allan", 
        "id": "sg:person.01110616655.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110616655.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Physiology, Frederiksberg Hospital", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine C, Diakonissestiftelsen", 
            "Department of Clinical Physiology, Frederiksberg Hospital"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Trap\u2010Jensen", 
        "givenName": "Jens", 
        "id": "sg:person.0101162757.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0101162757.39"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01975139", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036141189", 
          "https://doi.org/10.1007/bf01975139"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1985-03-23", 
    "datePublishedReg": "1985-03-23", 
    "description": "In a double-blind, randomized, crossover study, the effects of intravenous pinacidil, 0.2 mg/kg, were compared with those of hydralazine, 0.3 mg/kg, before and after beta-adrenoceptor blockade in six subjects with hypertension. Both drugs equally reduced total peripheral resistance by about 40%. Pinacidil reduced mean blood pressure by an average of 30 mm Hg, while the reduction after hydralazine was 10 mm Hg. The difference in antihypertensive effect resulted from greater increases in heart rate, cardiac contractility (systolic time intervals), and cardiac index (thermodilution) after hydralazine. These effects after hydralazine could not be fully abolished by beta-blockade, as could the effects after pinacidil. Pinacidil decreased pulmonary blood pressure, whereas there was a slight rise in pulmonary blood pressure after hydralazine. Forearm blood flow (venous occlusion strain gauge plethysmography) increased equally after both drugs; thus pinacidil decreased forearm vascular resistance more than hydralazine did. Serum concentrations of both drugs were within the therapeutic range and correlated with the fall in mean blood pressure. Five subjects complained of side effects after hydralazine, but none were reported after pinacidil. Hydralazine increased myocardial oxygen consumption (as estimated from the rate-pressure product) by 35%; there was no change after pinacidil. It is suggested that hydralazine has direct cardiostimulatory effects that limit its antihypertensive effectiveness. These effects increase myocardial oxygen consumption and may be responsible for the common and sometimes severe cardiovascular side effects of hydralazine.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/clpt.1985.36", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017409", 
        "issn": [
          "0009-9236", 
          "1532-6535"
        ], 
        "name": "Clinical Pharmacology & Therapeutics", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "37"
      }
    ], 
    "keywords": [
      "mean blood pressure", 
      "pulmonary blood pressure", 
      "blood pressure", 
      "myocardial oxygen consumption", 
      "side effects", 
      "severe cardiovascular side effects", 
      "direct cardiostimulatory effects", 
      "forearm vascular resistance", 
      "acute hemodynamic effects", 
      "beta-adrenoceptor blockade", 
      "total peripheral resistance", 
      "forearm blood flow", 
      "cardiovascular side effects", 
      "oxygen consumption", 
      "antihypertensive effectiveness", 
      "cardiac index", 
      "vascular resistance", 
      "antihypertensive effect", 
      "hemodynamic effects", 
      "essential hypertension", 
      "crossover study", 
      "peripheral resistance", 
      "cardiostimulatory effects", 
      "serum concentrations", 
      "therapeutic range", 
      "cardiac contractility", 
      "heart rate", 
      "blood flow", 
      "hydralazine", 
      "pinacidil", 
      "hypertension", 
      "drugs", 
      "greater increase", 
      "slight rise", 
      "subjects", 
      "Hg", 
      "blockade", 
      "contractility", 
      "effect", 
      "pressure", 
      "resistance", 
      "fall", 
      "index", 
      "differences", 
      "study", 
      "consumption", 
      "rate", 
      "increase", 
      "reduction", 
      "changes", 
      "concentration", 
      "average", 
      "effectiveness", 
      "rise", 
      "flow", 
      "range"
    ], 
    "name": "Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension", 
    "pagination": "253-259", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1048464171"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/clpt.1985.36"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "2857601"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/clpt.1985.36", 
      "https://app.dimensions.ai/details/publication/pub.1048464171"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_209.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/clpt.1985.36"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/clpt.1985.36'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/clpt.1985.36'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/clpt.1985.36'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/clpt.1985.36'


 

This table displays all metadata directly associated to this object as RDF triples.

242 TRIPLES      21 PREDICATES      105 URIs      95 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/clpt.1985.36 schema:about N16e33049951e49ed96b6ad17a6f920ca
2 N20689c34cfc741219776d83869b5d835
3 N220336a86a824f7ca8d5eb2845b4203b
4 N31a65d5ba7f04eb285366ccd4559e342
5 N4d58ae0f11204e84822cf4fcb57a40fe
6 N57b671f51b894fdfb132f6fe8994df48
7 N749b272d12954831aa4c79ad85dd2638
8 N82b2fed521f04dccbc2e74c7f7af20e9
9 N8570d04d521643168e8c234f0b7dab52
10 N96f54d2f59cc4a55b658397fe966631d
11 N9b4a251ef2964441af8bf7f0ffb0d36b
12 N9d4864e846884a84bb0d978ec3f370f1
13 N9ff6a53376c94e9fa5f0454c875e2870
14 Na029968eb70741758094c9605375ed57
15 Na2a529f5e5ac46bc9b830985eafed3cd
16 Na71a078b6ae7404dbd644b17da5bc343
17 Na84a64a2348b44ba83e0724920035dd6
18 Na85311d438564967bcc8dccf97754669
19 Nbe3558303a04468698680a10825fd349
20 Nbe7fa8913e234448a344212b243dc636
21 Ncca759d4a3bf4ca0b2ada70ca5d57237
22 Nd4f8d41744cd43b9ab1813bff707d41e
23 anzsrc-for:11
24 anzsrc-for:1102
25 anzsrc-for:1116
26 schema:author N64bf109099b04b92b424d90560e5b50e
27 schema:citation sg:pub.10.1007/bf01975139
28 schema:datePublished 1985-03-23
29 schema:datePublishedReg 1985-03-23
30 schema:description In a double-blind, randomized, crossover study, the effects of intravenous pinacidil, 0.2 mg/kg, were compared with those of hydralazine, 0.3 mg/kg, before and after beta-adrenoceptor blockade in six subjects with hypertension. Both drugs equally reduced total peripheral resistance by about 40%. Pinacidil reduced mean blood pressure by an average of 30 mm Hg, while the reduction after hydralazine was 10 mm Hg. The difference in antihypertensive effect resulted from greater increases in heart rate, cardiac contractility (systolic time intervals), and cardiac index (thermodilution) after hydralazine. These effects after hydralazine could not be fully abolished by beta-blockade, as could the effects after pinacidil. Pinacidil decreased pulmonary blood pressure, whereas there was a slight rise in pulmonary blood pressure after hydralazine. Forearm blood flow (venous occlusion strain gauge plethysmography) increased equally after both drugs; thus pinacidil decreased forearm vascular resistance more than hydralazine did. Serum concentrations of both drugs were within the therapeutic range and correlated with the fall in mean blood pressure. Five subjects complained of side effects after hydralazine, but none were reported after pinacidil. Hydralazine increased myocardial oxygen consumption (as estimated from the rate-pressure product) by 35%; there was no change after pinacidil. It is suggested that hydralazine has direct cardiostimulatory effects that limit its antihypertensive effectiveness. These effects increase myocardial oxygen consumption and may be responsible for the common and sometimes severe cardiovascular side effects of hydralazine.
31 schema:genre article
32 schema:isAccessibleForFree false
33 schema:isPartOf N23a715a9c7744cbeb55790eae8b1f21c
34 N37ff90389dd648d6aca64e5749e414cb
35 sg:journal.1017409
36 schema:keywords Hg
37 acute hemodynamic effects
38 antihypertensive effect
39 antihypertensive effectiveness
40 average
41 beta-adrenoceptor blockade
42 blockade
43 blood flow
44 blood pressure
45 cardiac contractility
46 cardiac index
47 cardiostimulatory effects
48 cardiovascular side effects
49 changes
50 concentration
51 consumption
52 contractility
53 crossover study
54 differences
55 direct cardiostimulatory effects
56 drugs
57 effect
58 effectiveness
59 essential hypertension
60 fall
61 flow
62 forearm blood flow
63 forearm vascular resistance
64 greater increase
65 heart rate
66 hemodynamic effects
67 hydralazine
68 hypertension
69 increase
70 index
71 mean blood pressure
72 myocardial oxygen consumption
73 oxygen consumption
74 peripheral resistance
75 pinacidil
76 pressure
77 pulmonary blood pressure
78 range
79 rate
80 reduction
81 resistance
82 rise
83 serum concentrations
84 severe cardiovascular side effects
85 side effects
86 slight rise
87 study
88 subjects
89 therapeutic range
90 total peripheral resistance
91 vascular resistance
92 schema:name Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension
93 schema:pagination 253-259
94 schema:productId N0e4a8c14f4974c60a2774fcfc779aa08
95 N164d9e0c679d45f295a83bd438debf38
96 Na34ba8a791dd478ea47855079cee593b
97 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048464171
98 https://doi.org/10.1038/clpt.1985.36
99 schema:sdDatePublished 2022-12-01T06:19
100 schema:sdLicense https://scigraph.springernature.com/explorer/license/
101 schema:sdPublisher N55462cac7f9247cabfbebf140df31773
102 schema:url https://doi.org/10.1038/clpt.1985.36
103 sgo:license sg:explorer/license/
104 sgo:sdDataset articles
105 rdf:type schema:ScholarlyArticle
106 N0e4a8c14f4974c60a2774fcfc779aa08 schema:name dimensions_id
107 schema:value pub.1048464171
108 rdf:type schema:PropertyValue
109 N164d9e0c679d45f295a83bd438debf38 schema:name pubmed_id
110 schema:value 2857601
111 rdf:type schema:PropertyValue
112 N16e33049951e49ed96b6ad17a6f920ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Guanidines
114 rdf:type schema:DefinedTerm
115 N20689c34cfc741219776d83869b5d835 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Injections, Intravenous
117 rdf:type schema:DefinedTerm
118 N220336a86a824f7ca8d5eb2845b4203b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Humans
120 rdf:type schema:DefinedTerm
121 N23a715a9c7744cbeb55790eae8b1f21c schema:issueNumber 3
122 rdf:type schema:PublicationIssue
123 N31a65d5ba7f04eb285366ccd4559e342 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Metoprolol
125 rdf:type schema:DefinedTerm
126 N37ff90389dd648d6aca64e5749e414cb schema:volumeNumber 37
127 rdf:type schema:PublicationVolume
128 N4d58ae0f11204e84822cf4fcb57a40fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Female
130 rdf:type schema:DefinedTerm
131 N55462cac7f9247cabfbebf140df31773 schema:name Springer Nature - SN SciGraph project
132 rdf:type schema:Organization
133 N57b671f51b894fdfb132f6fe8994df48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Vascular Resistance
135 rdf:type schema:DefinedTerm
136 N5bcc7159635d45f5b4dedb12985e9f65 rdf:first sg:person.015552033506.55
137 rdf:rest N5db28e7847b6477480a994d96a86483d
138 N5db28e7847b6477480a994d96a86483d rdf:first sg:person.0613041032.38
139 rdf:rest Na61c2bf3c7b344d2833c5533c083b32b
140 N64bf109099b04b92b424d90560e5b50e rdf:first sg:person.01172441075.89
141 rdf:rest N5bcc7159635d45f5b4dedb12985e9f65
142 N749b272d12954831aa4c79ad85dd2638 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Hemodynamics
144 rdf:type schema:DefinedTerm
145 N82b2fed521f04dccbc2e74c7f7af20e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Drug Interactions
147 rdf:type schema:DefinedTerm
148 N8570d04d521643168e8c234f0b7dab52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Heart Rate
150 rdf:type schema:DefinedTerm
151 N877164e78d8d40c4be24f55515bbef8c rdf:first sg:person.0101162757.39
152 rdf:rest rdf:nil
153 N96f54d2f59cc4a55b658397fe966631d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Middle Aged
155 rdf:type schema:DefinedTerm
156 N9b4a251ef2964441af8bf7f0ffb0d36b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Cardiac Output
158 rdf:type schema:DefinedTerm
159 N9d4864e846884a84bb0d978ec3f370f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Hydralazine
161 rdf:type schema:DefinedTerm
162 N9ff6a53376c94e9fa5f0454c875e2870 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Blood Pressure
164 rdf:type schema:DefinedTerm
165 Na029968eb70741758094c9605375ed57 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Male
167 rdf:type schema:DefinedTerm
168 Na2a529f5e5ac46bc9b830985eafed3cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Drug Evaluation
170 rdf:type schema:DefinedTerm
171 Na34ba8a791dd478ea47855079cee593b schema:name doi
172 schema:value 10.1038/clpt.1985.36
173 rdf:type schema:PropertyValue
174 Na61c2bf3c7b344d2833c5533c083b32b rdf:first sg:person.01110616655.46
175 rdf:rest N877164e78d8d40c4be24f55515bbef8c
176 Na71a078b6ae7404dbd644b17da5bc343 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Double-Blind Method
178 rdf:type schema:DefinedTerm
179 Na84a64a2348b44ba83e0724920035dd6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Adult
181 rdf:type schema:DefinedTerm
182 Na85311d438564967bcc8dccf97754669 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Pinacidil
184 rdf:type schema:DefinedTerm
185 Nbe3558303a04468698680a10825fd349 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Stroke Volume
187 rdf:type schema:DefinedTerm
188 Nbe7fa8913e234448a344212b243dc636 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Hypertension
190 rdf:type schema:DefinedTerm
191 Ncca759d4a3bf4ca0b2ada70ca5d57237 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Random Allocation
193 rdf:type schema:DefinedTerm
194 Nd4f8d41744cd43b9ab1813bff707d41e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Adrenergic beta-Antagonists
196 rdf:type schema:DefinedTerm
197 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
198 schema:name Medical and Health Sciences
199 rdf:type schema:DefinedTerm
200 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
201 schema:name Cardiorespiratory Medicine and Haematology
202 rdf:type schema:DefinedTerm
203 anzsrc-for:1116 schema:inDefinedTermSet anzsrc-for:
204 schema:name Medical Physiology
205 rdf:type schema:DefinedTerm
206 sg:journal.1017409 schema:issn 0009-9236
207 1532-6535
208 schema:name Clinical Pharmacology & Therapeutics
209 schema:publisher Springer Nature
210 rdf:type schema:Periodical
211 sg:person.0101162757.39 schema:affiliation grid-institutes:None
212 schema:familyName Trap‐Jensen
213 schema:givenName Jens
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0101162757.39
215 rdf:type schema:Person
216 sg:person.01110616655.46 schema:affiliation grid-institutes:None
217 schema:familyName McNair
218 schema:givenName Allan
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110616655.46
220 rdf:type schema:Person
221 sg:person.01172441075.89 schema:affiliation grid-institutes:None
222 schema:familyName Carlsen
223 schema:givenName Jan E
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172441075.89
225 rdf:type schema:Person
226 sg:person.015552033506.55 schema:affiliation grid-institutes:None
227 schema:familyName Kardel
228 schema:givenName Troels
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015552033506.55
230 rdf:type schema:Person
231 sg:person.0613041032.38 schema:affiliation grid-institutes:None
232 schema:familyName Lund
233 schema:givenName Jens O
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613041032.38
235 rdf:type schema:Person
236 sg:pub.10.1007/bf01975139 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036141189
237 https://doi.org/10.1007/bf01975139
238 rdf:type schema:CreativeWork
239 grid-institutes:None schema:alternateName Department of Clinical Physiology, Frederiksberg Hospital
240 schema:name Department of Clinical Physiology, Frederiksberg Hospital
241 Department of Internal Medicine C, Diakonissestiftelsen
242 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...